The influence of the patients' educational levels on socioeconomic, clinical, immunological and virological endpoints

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 21, Issue 4, 2009, Pages 511-519

  Collazos, Julio ^a   Asensi, Victor ^b   Carton, Jose Antonio ^b   Ibarra, Sofia ^c  

^a HOSPITAL DE GALDAKAO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

Author keywords

Antiretroviral therapy; CD4; Education; Outcomes; Socioeconomic factors; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; NELFINAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL EVALUATION; CLINICAL PRACTICE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOLOGY; MAJOR CLINICAL STUDY; MALE; PARAMETER; PATIENT EDUCATION; PRIORITY JOURNAL; SOCIAL ASPECT; SOCIOECONOMICS; TREATMENT OUTCOME; VIROTHERAPY; VIRUS LOAD; VIRUS TRANSMISSION; ADOLESCENT; AGED; ATTITUDE TO HEALTH; EDUCATIONAL STATUS; MIDDLE AGED; REGRESSION ANALYSIS; VIROLOGY;

ADOLESCENT; ADULT; AGED; CD4 LYMPHOCYTE COUNT; EDUCATIONAL STATUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALE; MIDDLE AGED; NELFINAVIR; REGRESSION ANALYSIS; SOCIOECONOMIC FACTORS; VIRAL LOAD; YOUNG ADULT;

EID: 67649388517     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120802270300     Document Type: Article

References (34)

1. Anastos, K., Gange, S.J., Lau, B., Weiser, B., Detels, R., Giorgi, J.V., et al. (2000). Association of race and gender with HIV-1 RNA levels and immunologic progression. Journal of Acquired Immune Deficiency Syndromes, 24, 218-226.
2. Antunes, J.L., Waldman, E.A., & Borrell, C. (2005). Is it possible to reduce AIDS deaths without reinforcing socioeconomic inequalities in health? International Journal of Epidemiology, 34, 586-592.
3. Borrell, C., Rodríguez-Sanz, M., Pasarín, M.I., Brugal, M.T., Garc?́a-de-Olalla, P., Mar?́-Dell'Olmo, M., et al. (2006). AIDS mortality before and after the introduction of highly active antiretroviral therapy: Does itvary with socioeconomic group in a country with a National Health System? European Journal of Public Health, 16, 601-608.
4. Caro-Murillo, A.M., Castilla, J., Pérez-Hoyos, S., Miró , J.M., Podzamczer, D., Rubio, R., et al. (2007). Spanish cohort of naïve HIV-infected patients (CoRIS): Rationale, organization and initial results. Enfermedades Infecciosas y Microbiolog?́a Cl?́nica, 25, 23-31.
5. Collazos, J., Asensi, V., & Carton, J.A. (2007). Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART. AIDS, 21, 835-843.
6. Davidson, A.J., Bertram, S.L., Lezotte, D.C., Marine, W.M., Rietmeijer, C.A., Hagglund, B.B., et al. (1998). Comparison of health status, socioeconomic characteristics, and knowledge and use of HIV-related resources between HIV-infected women and men. Medical Care, 36, 1676-1684.
7. Davoli, M., Perucci, C.A., Forastiere, F., Doyle, P., Rapiti, E., Zaccarelli, M., et al. (1993). Risk factors for overdose mortality: A case-control study within a cohort of intravenous drug users. International Journal of Epidemiology, 22, 273-277.
8. del Amo, J., del Romero, J., Barrasa, A., Pérez-Hoyos, S., Rodr?́guez, C., D?́ez, M., et al. (2002). Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999. Sexually Transmitted Infections, 78, 255-260.
9. Dray-Spira, R., & Lert, F. (2003). Social health inequalities during the course of chronic HIV disease in the era of highly active antiretroviral therapy. AIDS, 17, 283- 290.
10. Fardet, L., Mary-Krause, M., Heard, I., Partisani, M., & Costagliola, D. (2006). Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response. HIV Medicine, 7, 520-529.
11. Fleishman, J.A., Gebo, K.A., Reilly, E.D., Conviser, R., Christopher Mathews, W., Todd Korthuis, P., et al. (2005). Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002. Medical Care, 43(Suppl. 9), III40-52.
12. Gordillo, V., del Amo, J., Soriano, V., & Gonzá lez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763-1769.
13. Grabar, S., Kousignian, I., Sobel, A., Le Bras, P., Gasnault, J., Enel, P., et al. (2004). Immunological and clinical response to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital database on HIV. AIDS, 18, 2029-2038.
14. Hellinger, F.J., & Fleishman, J.A. (2001). Location, race, and hospital care for AIDS patients: An analysis of 10 states. Inquiry, 38, 319-330.
15. Hembree, C., Galea, S., Ahern, J., Tracy, M., Markham Piper, T., Miller, J., et al. (2005). The urban built environment and overdose mortality in New York City neighborhoods. Health Place, 11, 147-156.
16. Huisman, M., Kunst, A.E., Bopp, M., Borgan, J.K., Borrell, C., Costa, G., et al. (2005). Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations. Lancet, 365, 493-500.
17. Jarrin, I., Lumbreras, B., Ferreros, I., Pérez-Hoyos, S., Hurtado, I., & Hernández-Aguado, I. (2007). Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART. International Journal of Epide miology, 36, 187-194.
18. Junghans, C., Low, N., Chan, P., Witschi, A., Vernazza, P., & Egger, M. (1999). Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study. AIDS, 13, 2547-2554.
19. Katz, M.H., Hsu, L., Lingo, M., Woelffer, G., & Schwarcz, S.K. (1998). Impact of socioeconomic status on survival with AIDS. American Journal of Epidemiology, 148, 282-291.
20. Knobel, H., Alonso, J., Casado, J.L., Collazos, J., Gonzá - lez, J., Ruiz, I., et al. (2002). Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA study. AIDS, 16, 605-613.
21. Lundberg, O. (1993). The impact of childhood living conditions on illness and mortality in adulthood. Social Science & Medicine, 36, 1047-1052.
22. McFarland, W., Chen, S., Hsu, L., Schwarcz, S., & Katz, M. (2003). Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco. Journal of Acquired Immune Deficiency Syndromes, 33, 96-103.
23. Nemes, M.I., Carvalho, H.B., & Souza, M.F., Antiretroviral therapy adherence in Brazil. (2004). AIDS, 18(Suppl. 3), S15-S20.
24. Perez, J.L., & Moore, R.D. (2003). Greater effect of highly active antiretroviral therapy on survival in people aged ]50 years compared to younger people in an urban observational cohort. Clinical Infectious Diseases, 36, 212-218.
25. Piketty, C., Castiel, P., Giral, P., Lhomme, J.P., Boubilley, D., Olievenstein, C., et al. (1999). Lack of legal income is strongly associated with an increased risk of AIDS and death in HIV-infected injecting drug users. AIDS Care, 1, 429-436.
26. Rapiti, E., Porta, D., Forastiere, F., Fusco, D., & Perucci, C.A. (2000). Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy. Lazio AIDS Surveillance Collaborative Group. Epidemiology, 11, 496-501.
27. Rodr?́guez-Arenas, M.A., Jarr?́n, I., del Amo, J., Iribarren, J.A., Moreno, S., Viciana, P., et al. (2006). Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain. AIDS Research and Human Retroviruses, 22, 715-723.
28. Saraceni, V., da Cruz, M.M., Lauria, L., de, M., & Durovni, B. (2005). Trends and characteristics of AIDS mortality in the Rio de Janeiro city after the introduction of highly active antiretroviral therapy.The Brazilian Journal of Infectious Diseases, 9, 209- 215.
29. Schechter, M.T., Hogg, R.S., Aylward, B., Craib, K.J., Le, T.N., & Montaner, J.S. (1994). Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care. Journal of Clinical Epidemiology, 47, 59-67.
30. Steenland, K., Henley, J., & Thun, M. (2002). All-cause and cause-specific death rates by educational status for two million people in two American Cancer Society cohorts, 1959-1996. American Journal of Epidemiology, 156, 11-21.
31. Umeh, O.C., & Currier, J.S. (2005). Sex differences in HIV: Natural history, pharmacokinetics, and drug toxicity. Current Infectious Disease Reports, 7, 73-78.
32. von Overbeck, J., Egger, M., Smith, G.D., Schoep, M., Ledergerber, B., Furrer, H., et al. (1994). Survival in HIV infection: Do sex and category of transmission matter? Swiss HIV Cohort Study. AIDS, 8, 1307-1313.
33. Wallace, R.G. (2003). AIDS in the HAART era: New York's heterogeneous geography. Social Science & Medicine, 56, 1155-1171.
34. Wood, E., Montaner, J.S., Chan, K., Tyndall, M.W., Schechter, M.T., Bangsberg, D., et al. (2002). Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS, 16, 2065-2072.